Protection from pathogenic SIV challenge using multigenic DNA vaccines

Immunology Letters

Volumn 66, Issue 1-3, 1999, Pages 183-188

  Haigwood, Nancy L ^a   Pierce, Christopher C ^a   Robertson, Michael N ^b   Watson, Andrew J ^a   Montefiori, David C ^c   Rabin, Michael ^b   Lynch, John B ^b   Kuller, LaRene ^b   Thompson, Jannelle ^b   Morton, William R ^b   Benveniste, Raoul E ^d   Hu, Shiu Lok ^b   Greenberg, Philip ^b   Mossman, Sally P ^a,b  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Antibody; CTL; Cytokine; Genetic immunization; HIV 1; SIV; Vaccines

Indexed keywords

DNA VACCINE; GAG PROTEIN; GLYCOPROTEIN GP 160; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY; PLASMID DNA; POL PROTEIN; RECOMBINANT PROTEIN; VIRUS GLYCOPROTEIN;

ANIMAL MODEL; ANTIBODY TITER; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VIRUS INFECTION;

ANIMALS; COS CELLS; MACACA FASCICULARIS; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINES, DNA; VIRAL LOAD;

EID: 0033011905     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(98)00156-4     Document Type: Conference Paper

References (23)

1. Hu S.-L., Haigwood N.L., Morton W.R. Morrow W.J.W., Haigwood N.L. HIV molecular organization, pathogenicity and treatment. 1993;293-327 Amsterdam, Elsevier.
2. Hu S.-L., Abrams K., Barber G.N., Moran P., Zarling J.M., Langlois A.J., Kuller L., Morton W.R., Benveniste R.E. Science. 255:1992;456-459.
3. Giavedoni L.D., Planelles V., Haigwood N.L., Ahmad S., Kluge J.D., Marthas M.L., Gardner M.B., Luciw P.A., Yilma T.D. J. Virol. 67:1993;577-583.
4. Ahmad S., Lohman B., Marthas M., Giavedoni L, El-Amad Z., Haigwood N.L., Scandella C.J., Gardner M.B., Luciw P.A., Yilma T. AIDS Res. Hum. Retrovir. 10:1994;195-204.
5. Mossam S.P., Bex F., Berglund P., Arthos J., O'Neil S.P., Riley D., Maul D.H., Bruck C., Momin P., Fultz P.N., Burny A., Mullins J.I., Liljestrom P.E., Hoover E.A. J. Virol. 70:1996;1953-1960.
6. Daniel M.D., Kirchhoff F., Czajak S.C., Sehgal P.K., Desrosiers R.C. Science. 228:1992;1201-1204.
7. Wyand M.S., Manson K.H., Garcia-Moll M., Montefiori D., Desrosiers R.C. J. Virol. 70:1996;3724-3733.
8. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., EdWitt C.M., Friedman A., Hawe L.A., Leander KR, Mrtinex D., Perry H.C., Shiver J.W., Mongomery D.L., Liu M.A. Science. 259:1993;1745-1749.
9. Donnelly J.J., Friedman A., Martinez D., Montgomery D.L., Shiver J.W., Motzel S.L., Ulmer J.B., Liu M.A. Nat. Med. 1:1995;583-587.
10. Ertl H.C., Xiang Z.Q. Genetic Immunization. Viral lmmunol. 9:1996;1-9.
11. Donnelly J.J., Ulmer J.B., Shiver J.W., Liu M.A. DNA Vaccines. Ann. Rev. Immunol. 15:1997;617-648.
12. Boyer J.D., Ugen K.E., Wang B., Agadjanyan M., Gilbert L., Bagarazzi M.L., Chattergoon M., Frost P., Javadian A., Williams W.V., Refaeli Y., Ciccarelli R.B., McCallus D., Coney L., Weiner D.B. Nat. Med. 3:1997;526-532.
13. Letvin N.L., Montefiori D.C., Yasutomi Y., Perry H.C., Davis M.-E., Lekutis C., Alroy M., Freed D.C., Lord C.J., Handt L.K., Liu M.A., Shiver J.W. Proc. Natl. Acad. Sci. USA. 94:1997;9378-9383.
14. Lu S., Arthos J., Montefiori D.C., Yasutomi Y., Manson K., Mustafa F., Johnson E., Santoro J.C., Wissink J., Mullins J.I., Haynes J.R., Letvin N.L., Wyand M., Robinson H.L. J. Virol. 70:1996;3978-3991.
15. Fuller D.H., Simpson L., Cole K.S., Clements J.E., Panicali D., Montelaro R.C., Murphey-Corb M., Haynes J.R. Immunol. Cell Biol. 75:1997;389-396.
16. S.L. Hu, J.E. Klaniecki, B.M. Travis, T. Wrey, S. Pennathur, J.L. Thompson, M.B. Agy, L. Kuller, Y. Lu, D. Montefiori, W.R. Morton. 9th Annual Meeting of the National Cooperative Vaccine Development Groups for AIDS Bethesda, Maryland, Abstract 69, 1997.
17. Hu S.-L., Polacino P., Stallard V., Klaniecki J., Pennathur S., Travis B.M., Misher L., Kornas H., Langlois A.J., Morton W.R, Benveniste R.E. Hum. Lett. 51:1996;115-119.
18. Chapman B.S., Thayer R.M., Vincent K.A., Haigwood N.L. Nucl. Acids Res. 19:1991;3979-3986.
19. Cole K.S., Rowles J.L., Jagerski B.A., Murphey-Corb M., Unangst T., Clements J.E., Robioson J., Wyand M.S., Desrosiers R.C., Montelaro R.C. J. Virol. 71:1997;5069-5079.
20. Watson A., Ranchalis J., Travis B., McClure J., Sudon W., Johnson P.R., Hu S.-L., Haigwood N.L. J. Virol. 71:1997;284-290.
21. Mellors J.W., Kingsley L.A., Rinaldo C.R., Todd J.A., Hoo B.S., Kokka R.P., Gupta P. Ann. Int. Med. 122:1995;573-579.
22. Montefiori D.C., Robinson W.E., Schuffman S.S., Mitchell W.M. J. Clin. Microbiol. 26:1988;231-235.
23. Kent S.J., Corey L., Agy M.B., Morton W.R., McElrath M.J., Greenberg P.D. J. Clin. Invest. 95:1995;248-256.